20/20 Biolabs, Inc. — Form 8-K
Filed September 18, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
20/20 Biolabs filed an 8-K on 2026-09-18 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) for a period ending 2026-09-16. The filing contains no substantive disclosure of what was voted on, vote counts, outcomes, or financial impact. The actual details of the shareholder matter are not provided in the available filing documents.
Why this rating
Filing is procedurally required but lacks material content disclosure. Cannot assess business impact without knowing vote subject, results, or financial stakes relative to $6.1M asset base.
Extracted items
See more from September 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.